The IBN SINA Pharmaceutical Industry PLC (DSE:IBNSINA)

Market Cap	10.07B
Revenue (ttm)	12.84B
Net Income (ttm)	769.78M
Shares Out	31.24M
EPS (ttm)	24.64
PE Ratio	13.08
Forward PE	n/a
Dividend	6.40 (1.99%)
Ex-Dividend Date	Oct 27, 2025

Volume	5,895
Average Volume	32,800
Open	319.00
Previous Close	323.90
Day's Range	319.00 - 324.90
52-Week Range	273.80 - 334.80
Beta	0.12
RSI	59.29
Earnings Date	Jan 26, 2026

About DSE:IBNSINA

The IBN SINA Pharmaceutical Industry PLC produces and sells pharmaceutical drugs in Bangladesh and internationally. The company provides its products in various forms, such as solid dosage forms consisting of tablets and capsules; parenteral products covering ampoules and vials; liquid dosage forms comprising syrups, solutions, suspensions, and powder for suspension (dry syrups); and sterile ophthalmic products, creams, ointments, gels, eye drops and sachet, etc. It also offers various therapeutic products, including analgesic and anti-inflamma...

• Industry: Pharmaceutical Preparations
• Founded: 1983
• Employees: 5,200
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: IBNSINA

Financial Performance

In 2025, DSE:IBNSINA's revenue was 11.88 billion, an increase of 4.51% compared to the previous year's 11.37 billion. Earnings were 633.19 million, a decrease of -5.57%.